EQUITY RESEARCH MEMO

Asia Regulatory and Quality Consultancy

Generated 5/22/2026

Executive Summary

Conviction (model self-assessment)72/100

Asia Regulatory and Quality Consultancy (ARQon) is a Singapore-based firm providing end-to-end regulatory, quality, and market-access services for medical devices, pharmaceuticals, cosmetics, and health products. Leveraging a team of former regulators and industry experts, ARQon offers product registration, ISO/GDP compliance, and digital platforms like ATTOPOLIS and QuikQuality that connect startups with investors, distributors, and clinical partners. Founded in 2020, the company has grown to 50-200 employees and operates at a commercial stage, serving clients across Asia. With the increasing complexity of Asian regulatory landscapes and growing demand for market-access support, ARQon is well-positioned to capture market share. Its dual focus on consultancy and digital ecosystem differentiates it from traditional consultancies, potentially accelerating client time-to-market.

Upcoming Catalysts (preview)

  • Q3 2026Launch of enhanced QuikQuality digital quality management platform70% success
  • Q4 2026Strategic partnership with major ASEAN health authority for streamlined registration55% success
  • Q1 2027Potential ISO 13485 certification for in-house medical device consulting services80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)